7-107952179-C-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_002291.3(LAMB1):c.3124G>A(p.Gly1042Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000244 in 1,613,056 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_002291.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAMB1 | NM_002291.3 | c.3124G>A | p.Gly1042Ser | missense_variant | 23/34 | ENST00000222399.11 | NP_002282.2 | |
LAMB1 | XM_047420359.1 | c.3124G>A | p.Gly1042Ser | missense_variant | 23/28 | XP_047276315.1 | ||
LAMB1 | XM_047420360.1 | c.3124G>A | p.Gly1042Ser | missense_variant | 23/25 | XP_047276316.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAMB1 | ENST00000222399.11 | c.3124G>A | p.Gly1042Ser | missense_variant | 23/34 | 1 | NM_002291.3 | ENSP00000222399.6 |
Frequencies
GnomAD3 genomes AF: 0.000512 AC: 78AN: 152206Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000731 AC: 183AN: 250432Hom.: 1 AF XY: 0.000717 AC XY: 97AN XY: 135344
GnomAD4 exome AF: 0.000215 AC: 314AN: 1460732Hom.: 1 Cov.: 31 AF XY: 0.000204 AC XY: 148AN XY: 726444
GnomAD4 genome AF: 0.000519 AC: 79AN: 152324Hom.: 1 Cov.: 33 AF XY: 0.000416 AC XY: 31AN XY: 74484
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Oct 13, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jun 01, 2024 | LAMB1: BP4, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 09, 2018 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
LAMB1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 12, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at